Erlotinib

Overview

Erlotinib is a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells.

API suppliers (4)

Suppliers of Erlotinib backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• MSN Laboratories Private LimitedIndia2 active DMF
• PHARMAZELL INDIA PRIVATE LTD2 active DMF
• CADILA HEALTHCARE LTD ZYFINE
• Cadila Healthcare LimitedIndia

Therapeutic areas